Inhibition of FOS-Like Antigen 1 Reduces Chemoresistance to Temozolomide Through Stemness Reprogramming via IL-6/STAT3(Tyr705) Pathway.
抑制 FOS 样抗原 1 通过 IL-6/STAT3(Tyr705) 通路进行干性重编程,从而降低对替莫唑胺的化疗耐药性。
期刊:MedComm
影响因子:10.7
doi:10.1002/mco2.70593
Sim JeongMin, Park JeongMan, Heo JinHyung, Kim Yu Jin, Kim Dongkil, Jeon Yong Hyun, Lee Jae-Eon, Choi Seon Hee, Kim Hak Jin, Hwang So Jung, Kim Junhyung, Cho Kyung Gi, Yoo Jihwan, Moon Ju Hyung, Moon Jong-Seok, Sung Kyoung Su, Lim Jaejoon